890
Views
22
CrossRef citations to date
0
Altmetric
Original Research Articles

Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000–2012

, , , , , , , , & show all
Article: 29798 | Received 18 Sep 2015, Accepted 07 Dec 2015, Published online: 12 Jan 2016

References

  • Slack MPE. Borriello SP, Murray PR, Funke G. Haemophilus. Topley & Wilson's microbiology and microbial infections. 2006; London, UK: Hodder Arnold. 1692–718. 10th ed..
  • Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae . J Exp Med. 1931; 53: 471–92.
  • Mason EO, Kaplan SL, Lamberthm LB, Hinds DB, Kvernland SJ, Loiselle EM, etal. Serotype and ampicillin susceptibility of Haemophilus influenzae causing systemic infections in children: 3 years of experience. J Clin Microbiol. 1982; 15: 543–6.
  • Falla TJ, Dobson SRM, Crook DWM, Kraak WAG, Nichols WW, Anderson EC, etal. Population-based study of non-typeable Haemophilus influenzae disease in children and neonates. Lancet. 1993; 341: 851–4.
  • Shapiro ED, Ward JL. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol Rev. 1991; 13: 113–42.
  • Ward JL, Lam MKW, Hall DB. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis. 1986; 153: 17–26.
  • Hammond GW, Rutherford BE, Maazdrewic R, MacFarlane N, Pillay N, Tate RB, etal. Haemophilus influenzae meningitis in Manitoba and the Keewatin District, NWT: potential for mass vaccination. Can Med Assoc J. 1988; 139: 743–7.
  • Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010; 28: 4073–8.
  • Bender J, Cox CM, Mottice S, She RC, Korenski K, Daly JA, etal. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis. 2010; 50: e41–6.
  • Tsang RSW, Mubareka S, Sill ML, Wylie J, Skinner S, Law DKS. Invasive Haemophilus influenzae in Manitoba, Canada, in the post-vaccination era. J Clin Microbiol. 2006; 44: 1530–5.
  • Bruce MG, Deeks SL, Zulz T, Navarro C, Palaclos C, Case C, etal. Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000–2005. Emerg Infect Dis. 2008; 14: 48–55.
  • Public Health Agency of Canada. Case definitions for communicable diseases under national surveillance. Can Commun Dis Rep. 2009; 35(Suppl 2): 65–8.
  • Ledeboer NA, Doern GV. Versalovic J, Carroll KC, Jorgensen JH, Funke G, Landry ML, Warnock DW. Haemophilus. Manual of clinical microbiology. 2011; Washington, DC: ASM Press. 588–602. 10th ed.
  • Kilian M. A taxonomic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol. 1976; 93: 9–62.
  • Murphy TF, Brauer AL, Sethi S, Kilian M, Cai X, Lesse AJ. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae . J Infect Dis. 2007; 195: 81–9.
  • Lau SKP, Woo PCY, Mok MY, Teng JLL, Tam VKP, Chan KKH, etal. Characterization of Haemophilus segnis, an important cause of bacteremia, by 16S rRNA gene sequencing. J Clin Microbiol. 2004; 42: 877–80.
  • Falla TJ, Crook DWM, Brohpy LN, Maskell D, Kroll JS, Moxon ER. PCR for capsule typing of Haemophilus influenzae . J Clin Microbiol. 1994; 32: 2382–6.
  • Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, etal. Characterization of encapsulated and non-encapsulated Haemophilus influenzae and determination of phylogenetic relationships by multi-locus sequencing typing. J Clin Microbiol. 2003; 41: 1623–36.
  • St Sauver J, Marrs CF, Foxman B, Somsel P, Madera R, Gilsdorf JR. Risk factors for otitis media and carriage of multiple strains of Haemophilus influenzae and Streptococcus pneumonia . Emerg Infect Dis. 2000; 6: 622–30.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th Informational Supplement, CLSI Document M100-S23. 2013; Wayne, PA: Clinical and Laboratory Standards Institute.
  • Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clin Infect Dis. 1996; 22: 1069–76.
  • Sill ML, Law DK, Zhou J, Skinner S, Wylie J, Tsang RS. Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006. FEMS Immunol Med Microbiol. 2007; 51: 270–6.
  • Tsang RSW. Serotyping and population genetics of invasive Haemophilus influenzae . J Clin Microbiol. 2008; 46: 1159.
  • Musser JM, Kroll JS, Moxon ER, Selander RK. Clonal population structure of encapsulated Haemophilus influenzae . Infect Immun. 1988; 56: 1837–45.
  • Musser JM, Kroll SJ, Moxon ER, Selander RK. Evolutionary genetics of the encapsulated strains of Haemophilus influenzae . Proc Natl Acad Sci USA. 1988; 85: 7758–62.
  • Tsang RSW, Shuel M, Wylie J, Lefebvre B, Hoang L, Law DKS. Population genetics of Haemophilus influenzae serotype a in three Canadian provinces. Can J Microbiol. 2013; 59: 362–4.
  • Crisel RM, Baker RS, Dorman DE. Capsular polymer of Haemophilus influenzae type b. I. Structural characterization of the capsular polymer of strain Eagan. J Biol Chem. 1975; 250: 4926–30.
  • Branefors-Helander P. The structure of the capsular antigen from Haemophilus influenzae type a. Carbohydr Res. 1977; 56: 117–22.
  • Kroll JS, Moxon ER, Loynds BM. An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b. J Infect Dis. 1993; 168: 172–6.
  • Kroll JS, Moxon ER, Loynds BM. Natural genetic transfer of a putative virulence-enhancing mutation to Haemophilus influenzae type a. J Infect Dis. 1994; 169: 676–9.
  • Bruce MG, Zulz T, DeByle C, Singleton R, Hurlburt D, Bruden D, etal. Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983–2011. Emerg Infect Dis. 2013; 19: 932–7.
  • Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae . Clin Microbiol Rev. 2007; 20: 368–89.
  • Shuel M, Whyte K, Drew T, Wylie J, Lefebvre B, Hoang L, etal. Differential susceptibility of invasive Haemophilus influenzae serotype a and serotype b to ampicillin and other commonly prescribed antibiotics. Lett Appl Microbiol. 2014; 59: 193–9.
  • Ulanova M, Tsang RSW. Haemophilus influenzae serotype a as a cause of serious invasive infections. Lancet Infect Dis. 2014; 14: 70–82.
  • Plumb I, Lecy K, Singleton R, Engel MC, Hirschfeld M, Klejka J, etal. Invasive Haemophilus influenzae serotype A infection in children, clinical description of an emerging pathogen – Alaska, 2002–2014. IDWeek 2015. San Diego, California, USA: Infectious Diseases Society of America. Abstract number 1339. Available from: https://idsa.confex.com/idsa/2015/webprogram/Paper50693.html .
  • Hammitt LL, Block S, Hennessy TW, DeByle C, Peters H, Parkinson A, etal. Outbreak of invasive Haemophilus influenzaeserotype a disease. Pediatr Infect Dis J. 2005; 24: 453–6.
  • Whyte K, Levett PN, Horsman GB, Chokani K, Hayden K, Shuel M, etal. Recurrent invasive Haemophilus influenzae serotype a infection in an infant. Microbiol Discov. 2015; 3: 4. http://dx.doi.org/10.7243/2052-6180-3-4 .
  • Ulanova M, Tsang R, Altman E. Conference report: neglected infectious diseases in aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori . Vaccine. 2012; 30: 6960–6.
  • Desai S, Tsang R, St-Laurent M, Cox A. Collaboration on a public health driven vaccine initiative. Can Commun Dis Rep. 2014; 40: 365–8.